Uremic Cardiomyopathy — An Endogenous Digitalis Intoxication ? Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy . Hypertension 47 : 488 – 495
E. Ritz
Abstract:S ince the days of Richard Bright (1), it has been common knowledge that the heart is a target organ in uremia, and by the beginning of the 20th century it had been recognized that heart failure and cardiac death were frequent in renal patients (2). Despite the common occurrence of failing heart function, as early as 1937 Mason had reported that the contractile force of frog hearts was augmented when exposed to the serum of uremic dogs, but not of control dogs (3). This was confirmed in the study of Nivatpumin (4). One potential explanation for the paradoxical initial increase in cardiac inotropy, later followed by pump failure, was the presence of a hypothetical, endogenous, digitalis-like substance that had been found in other systems, e.g., erythrocytes (5). Indeed, Penpargkul (6) and Fiehn (7) documented inhibition of the sarcolemmal Na,K-ATPase in the heart of uremic animals and we found similar inhibition of this enzyme also in extracardiac organs, e.g., the inner ear membranes (8). Around this time, inhibitors of the ouabain-sensitive Na ,K -ATPase, called “digoxin-like” (9), were also found in the urine and serum of uremic and of volume-expanded patients (8,9). Serum of uremic patients interfered with the radiorubidium assays for digitalis (10); this observation and the reduced inotropic dose-response relationship to digoxin in uremic animals (11) led several authors to the conclusion that in uremic animals endogenous digoxin-like substances were present, presumably in supranormal concentrations. The presence of endogenous digitalis in normal mammals had been postulated half a century ago (12). Based on the finding of (an) endogenous inhibitor(s) of Na -K -ATPase, Bricker (13), Nutbourne et al. (14), and Blaustein et al. (15) proposed the ingenious hypothesis that this inhibitor constituted part of a homeostatic feedback system, the task of which was to maintain the constancy of the extracellular fluid spaces (16) and of blood pressure (17). Digitalis-like substances are widely distributed in nature and almost certainly have important functions, as suggested by the fact that the substance in the phylogenetically-distant foxglove fits onto the mammalian receptor—although, clearly, weird coincidences can never be completely excluded. There have been numerous attempts to isolate and chemically characterize the hypothetical endogenous “digitalis,” i.e., inhibitor of the Na -K -ATPase. The quest to identify the chemical nature of the substance was for a long time painfully frustrating, but finally rewarding (18,19). Ouabain, the long-known arrow poison of the African ouabaio tree and of the Strophantus gratus plant, was identified as a new steroid hormone that is synthesized in the zona fasciculata of the adrenal cortex, in the extreme case illustrated by ouabain-producing adrenal tumors, ouabainomas, causing hypertension. Apparent triggers for the synthesis are ACTH, alpha adrenergic and dopaminergic (20) stimulation, angiotensin II, vasopressin, as well as systemic hypoxia and physical exercise (21). Ouabain is also found in the hypothalamus as a neurosteroid and can be detected in the circulation. Its concentration is elevated in congestive heart failure and renal failure (21,22). Ouabain antibodies or the newly discovered antagonist PST 2238 (23) inhibit ouabain-induced hypertension in experimental models. Of considerable importance with respect to the following is the recent observation that ouabain (and other cardiotonic steroids) act not only as inotropic agents and as inhibitors of the Na -K -ATPase, but also trigger intracellular signaling cascades. In the heart muscle, ouabain causes a Ca -dependent early gene response (c-fos, c-jun), stimulates Ras and p42/44, and increases protein biosynthesis (24). In vascular smooth muscle cells, both ouabain and marinobufagenin also stimulate proliferation at concentrations lower than those normally required to alter intracellular ion concentrations (25). What is really exciting is the identification of additional cardiotonic steroids with overlapping